Cboe UK EUR
Stellantis N.V. (STLAMM.XC)
8.47
-0.10
(-1.11%)
At close: June 3 at 9:17:05 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 1 | 27 | 26 |
| Avg. Estimate | 35.92B | 39.2B | 155.04B | 162.55B |
| Low Estimate | 34.46B | 39.2B | 145.56B | 152.86B |
| High Estimate | 38.95B | 39.2B | 162.7B | 176.46B |
| Year Ago Sales | 41.7B | 43.32B | 156.88B | 155.04B |
| Sales Growth (year/est) | -13.86% | -9.50% | -1.17% | 4.84% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| STLAMM.XC | -- | -- | -- | -- |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Downgrade | UBS: Buy to Neutral | 4/14/2025 |
| Downgrade | Piper Sandler: Overweight to Neutral | 3/20/2025 |
| Downgrade | RBC Capital: Outperform to Sector Perform | 10/4/2024 |
| Downgrade | Barclays: Overweight to Equal-Weight | 10/3/2024 |
| Downgrade | Jefferies: Buy to Hold | 8/7/2024 |
| Upgrade | Nomura: Neutral to Buy | 7/31/2024 |